Literature DB >> 18446431

Prenatal screening for infectious diseases: an analysis of disparities and adherence to policy in California.

Lamiya A Sheikh1, Clea Sarnquist, Erin Moix Grieb, Barbara Sullivan, Yvonne A Maldonado.   

Abstract

OBJECTIVES: Prenatal infectious diseases are a major cause of mortality and morbidity among newborns, but many are preventable with proper maternal screening and treatment. METHODS; Adherence to prenatal infectious disease screening guidelines and demographic factors that influence adherence were determined utilizing existing data on 1837 live births from 1999-2003.
RESULTS: We found higher rates of testing for syphilis (94.54%), rubella (92.69%) and hepatitis B (94.23%) than for HIV (73.82%) and GBS (69.05%). Adherence to testing guidelines varied by both disease and maternal factors. Lack of insurance, geographic location, inadequate prenatal care and incarceration were the main maternal factors associated with lack of testing.
CONCLUSIONS: Disease screening rates may be improved by reducing socioeconomic barriers to prenatal testing, supporting access to insurance, eliminating provider biases and providing adequate prenatal care.

Entities:  

Mesh:

Year:  2008        PMID: 18446431     DOI: 10.1007/s10995-008-0341-5

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  33 in total

1.  Revised recommendations for HIV screening of pregnant women.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2001-11-09

2.  Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2001-07-13

3.  National and state trends in use of prenatal care, 1970-83.

Authors:  D D Ingram; D Makuc; J C Kleinman
Journal:  Am J Public Health       Date:  1986-04       Impact factor: 9.308

4.  Testing pregnant women for HIV: a survey of obstetricians and review of patient prenatal/obstetric medical records--Connecticut 1996-1997.

Authors:  A Roome; K Carley; R Melchreit; G Foye; J Hadler
Journal:  Conn Med       Date:  1999-09

5.  Sexually transmitted disease screening by United States obstetricians and gynecologists.

Authors:  Matthew Hogben; Janet S St Lawrence; Danuta Kasprzyk; Daniel E Montano; George W Counts; Donna H McCree; William Phillips; Marianne Scharbo-DeHaan
Journal:  Obstet Gynecol       Date:  2002-10       Impact factor: 7.661

6.  HIV testing among pregnant women--United States and Canada, 1998-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-11-15       Impact factor: 17.586

7.  Assessment of screening, treatment, and prevention of perinatal infections in the Philadelphia birth cohort.

Authors:  Amy B Jessop; Barbara Watson; Rebecca Mazar; Jocelyn Andrel
Journal:  Am J Med Qual       Date:  2005 Sep-Oct       Impact factor: 1.852

8.  Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-04-18       Impact factor: 17.586

9.  Access to prenatal care following major Medicaid eligibility expansions.

Authors:  P Braveman; T Bennett; C Lewis; S Egerter; J Showstack
Journal:  JAMA       Date:  1993-03-10       Impact factor: 56.272

10.  Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-05-31
View more
  2 in total

1.  Trends and correlates of HIV testing during pregnancy in racially/ethnically diverse insured population, 1997-2006.

Authors:  Jean M Lawrence; In-Lu A Liu; William J Towner
Journal:  Matern Child Health J       Date:  2008-08-19

2.  Syphilis testing adherence among women with livebirth deliveries: Indianapolis 2014-2016.

Authors:  Opeyemi C Ojo; Janet N Arno; Guoyu Tao; Chirag G Patel; Brian E Dixon
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-30       Impact factor: 3.105

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.